RC
Repligen Corporation
RGEN· Health Care· BiotechnologyS&P 400
Close · 10/09/2026
164.68
1D
-0.22%52-week range
100.99 – 188.73
Volume
9,55,900.00
Price history
RGEN
11/08/2026 to 10/09/2026
O 162.68 H 165.04 L 161.14
1W-4.78%
1M-0.05%
3M+25.94%
6M+38.12%
1Y+38.75%
3Y-2.79%
5Y-42.39%
MAX-20.20%
Fundamentals
as of 10/09/2026- Market cap
- $9.29B
- Shares out
- 56.44M
- P/E (trailing)
- 223.74
- P/E (forward)
- 63.54
- EPS (trailing)
- 0.74
- Beta
- 1.05
- Profit margin
- 5.29%
- P/B
- 4.40
- Return on equity
- 1.97%
SEC financial statements
59 quarterly and 17 annual periods through 30/06/2026.
Details
- Ticker
- RGEN
- Index
- SP400
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 10/09/2026.
Tracked by Congress
2 filers · 0 on watchlist · 3 buys · 4 sells · R: 7
- 31/10/2025Lisa McClainSellRepligen Corporation - Common Stock$1,001–$15,000
- 30/10/2025Lisa McClainSellRepligen Corporation - Common Stock$1,001–$15,000
- 30/10/2025Lisa McClainBuyRepligen Corporation - Common Stock$1,001–$15,000
- 22/07/2025Lisa McClainBuyRepligen Corporation - Common Stock$1,001–$15,000
- 17/06/2025Lisa McClainSell+Repligen Corporation - Common Stock$1,001–$15,000
- 11/06/2025Lisa McClainBuyRepligen Corporation - Common Stock$1,001–$15,000
- 07/04/2025Jefferson ShreveSellRepligen Corporation - Common Stock$15,001–$50,000